GNTLF (Genetic Technologies) Shares Buyback Ratio % : -14.56 (As of May. 04, 2025)

View and export this data going back to 2002. Start your Free Trial

What is Genetic Technologies Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Genetic Technologies's current shares buyback ratio was -14.56%.

Genetic Technologies Shares Buyback Ratio % Historical Data

The historical data trend for Genetic Technologies's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Technologies Shares Buyback Ratio % Chart

Genetic Technologies Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-138.68

-20.00

-2.41

-24.99

-14.56

Genetic Technologies Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-	-14.56	-

Genetic Technologies Shares Buyback Ratio % Calculation

Genetic Technologies's Shares Buyback Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2023 )	-	Shares Outstanding (EOP) (A: Jun. 2024 ))	/	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	(115.417	-	132.217)	/	115.417
	=	-14.56%

Genetic Technologies's Shares Buyback Ratio for the quarter that ended in Jun. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Mar. 2024 )	-	Shares Outstanding (EOP) (A: Jun. 2024 ))	/	Shares Outstanding (EOP) (A: Mar. 2024 )
	=	(115.417	-	132.217)	/	115.417
	=	-14.56%

Genetic Technologies Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Technologies Ltd (OTCPK:GNTLF) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065

Website

https://www.gtglabs.com

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.